On March 28, 2022 Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, reported that Vish Seshadri, Ph.D., Chief Executive Officer of Abeona Therapeutics, will participate in a panel discussion titled, "Cell Therapy: How the Definition has Expanded with Time, and the Potential Applications for Rare Diseases," at the Cantor Fitzgerald Virtual Rare Disease Summit on Wednesday, March 30, 2022 at 4:00 p.m. ET (Press release, Abeona Therapeutics, MAR 28, 2022, View Source [SID1234611045]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Those interested in participating in the Cantor Fitzgerald Virtual Rare Orphan Disease Summit are encouraged to contact their Cantor Fitzgerald representative.